Market Overview

Biopredic Chooses Science Exchange as its Primary Online Channel to Offer Human and Animal Biological Products

Share:

Science Exchange, the leading marketplace for outsourced R&D™,
has announced a collaboration with Biopredic,
a privately-owned French biotechnology company, to offer a suite of
human and biological products, including its unique HepaRG® hepatic cell
model.

Biopredic is based in Saint-Grégoire, France, and is a leading provider
of hepatocytes and other hepatic systems for drug research. Biopredic's
expertise was initially based on primary hepatocyte cryopreservation and
quickly grew to encompass the isolation, production, and distribution of
fresh and frozen human and animal biological products, including
tissues, primary cells, cell lines, and reagents. The company recently
launched human liver microsomes called Silensomes™ designed for fm
measurement (fraction metabolized) along FDA and EMEA guidelines for
characterizing drug metabolism.

"We are pleased to use Science Exchange as our new platform for making
our products and services widely available to a global research
community", says Christophe Chesné, CEO of Biopredic International.
"Science Exchange's global presence will help us expand into new
markets."

"Biopredic is a leading provider of predictive model systems, and we are
excited to bring them on board," stated Elizabeth Iorns, PhD, founder
and CEO of Science Exchange. "As demonstrated by this collaboration and
many others, Science Exchange strives to give its users access to the
best-qualified and most innovative providers."

About Science Exchange

Science Exchange is the world's leading marketplace for outsourced
R&D™
, providing large R&D organizations with the fastest path
from discovery through development and commercialization. Science
Exchange includes an efficient source-to-secure platform for ordering
6,000+ services from a network of more than 2,500 qualified outsourced
research providers, all with pre-established contracts in place that
protect client intellectual property and confidentiality. The platform
increases access to innovation and improves productivity, freeing
scientists from administrative tasks and delays associated with
sourcing, establishing and managing service provider contracts.
Additionally, the Science Exchange enterprise program enables large R&D
organizations to consolidate research outsourcing spend into a single
strategic relationship, driving efficiency, improving transparency and
oversight, and delivering cost savings. Since being founded in 2011,
Science Exchange has raised more than $58 million from Norwest Venture
Partners, Maverick Capital Ventures, Union Square Ventures,
Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and
others. For more information, visit www.ScienceExchange.com.
Follow the company on Twitter @ScienceExchange,
Facebook,
and LinkedIn.

About Biopredic

Founded in 1993, Biopredic provides biological research products to the
life sciences industry. The key line of products derived from the liver,
the skin, and the blood which has wide-ranging applications in drug
metabolism, drug-drug interaction, pharmacokinetics, and toxicology
areas. Biopredic has a large tissue acquisition network, fully auditable
in a matter of ethics, traceability and sanitary compliances. The
products are provided fresh and frozen, as such or processed along our's
or the customer's specifications.

View Comments and Join the Discussion!